Retrieve available abstracts of 5 articles: HTML format
Single Articles
March 2025
DE MOURA DE SOUZA M, Mendes BX, Defante MLR, de Athayde de Hollanda Morais BA, et al Apolipoprotein C-III inhibitors for the treatment of hypertriglyceridemia: A
meta-analysis of randomized controlled trials.
Metabolism. 2025 Mar 10:156187. doi: 10.1016/j.metabol.2025.156187. PubMedAbstract available
July 2024
HAGVE M, Pereira SL, Walker DK, Engelen MPKJ, et al Statin treatment reduces leucine turnover, but does not affect endogenous
production of beta-hydroxy-beta-methylbutyrate (HMB).
Metabolism. 2024;156:155920. PubMedAbstract available
November 2023
ZUO F, Wang Y, Xu X, Ding R, et al CCDC92 deficiency ameliorates podocyte lipotoxicity in diabetic kidney disease.
Metabolism. 2023 Nov 10:155724. doi: 10.1016/j.metabol.2023.155724. PubMedAbstract available
July 2023
WANG YD, Wu LL, Mai YN, Wang K, et al miR-32-5p induces hepatic steatosis and hyperlipidemia by triggering de novo
lipogenesis.
Metabolism. 2023 Jul 12:155660. doi: 10.1016/j.metabol.2023.155660. PubMedAbstract available
April 2023
LARSSON SC, Michaelsson K, Mola-Caminal M, Hoijer J, et al Corrigendum to "Genome-wide association and Mendelian randomization study of
fibroblast growth factor 21 reveals causal associations with hyperlipidemia and
possibly NASH" [Metab Volume 137, December 2022, 155329].
Metabolism. 2023;143:155555. PubMed